BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30035010)

  • 1. Lower
    Joling M; Vriend C; van der Zande JJ; Lemstra AW; van den Heuvel OA; Booij J; Berendse HW
    Neuroimage Clin; 2018; 19():130-136. PubMed ID: 30035010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
    Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
    Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An
    van der Zande JJ; Joling M; Happach IG; Vriend C; Scheltens P; Booij J; Lemstra AW
    Neuroimage Clin; 2020; 25():102062. PubMed ID: 31790878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Extrastriatal
    Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J
    J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
    [No Abstract]   [Full Text] [Related]  

  • 5. Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a
    Pilotto A; Schiano di Cola F; Premi E; Grasso R; Turrone R; Gipponi S; Scalvini A; Cottini E; Paghera B; Garibotto V; Rizzetti MC; Bonanni L; Borroni B; Morbelli S; Nobili F; Guerra UP; Perani D; Padovani A
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1642-1651. PubMed ID: 31098748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.
    Colloby SJ; Williams ED; Burn DJ; Lloyd JJ; McKeith IG; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1176-85. PubMed ID: 15931516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
    O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
    Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.
    Walker Z; Costa DC; Walker RW; Lee L; Livingston G; Jaros E; Perry R; McKeith I; Katona CL
    Neurology; 2004 May; 62(9):1568-72. PubMed ID: 15136683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrastriatal
    Nicastro N; Fleury V; Broc N; Burkhard PR; Garibotto V
    Parkinsonism Relat Disord; 2020 Sep; 78():38-43. PubMed ID: 32698058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preserved Extrastriatal
    Nicastro N; Burkhard PR; Garibotto V
    Mol Imaging Biol; 2020 Dec; 22(6):1592-1599. PubMed ID: 32468408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
    McKeith I; O'Brien J; Walker Z; Tatsch K; Booij J; Darcourt J; Padovani A; Giubbini R; Bonuccelli U; Volterrani D; Holmes C; Kemp P; Tabet N; Meyer I; Reininger C;
    Lancet Neurol; 2007 Apr; 6(4):305-13. PubMed ID: 17362834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies.
    Taylor JP; Colloby SJ; McKeith IG; Burn DJ; Williams D; Patterson J; O'Brien JT
    J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1069-71. PubMed ID: 17299017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.
    Morgan S; Kemp P; Booij J; Costa DC; Padayachee S; Lee L; Barber C; Carter J; Walker Z
    J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1063-70. PubMed ID: 22869921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin transporter binding and anxiety symptoms in Parkinson's disease.
    Joling M; van den Heuvel OA; Berendse HW; Booij J; Vriend C
    J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):89-94. PubMed ID: 28899958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aging and gender on striatal and extrastriatal [123I]FP-CIT binding in Parkinson's disease.
    Kaasinen V; Joutsa J; Noponen T; Johansson J; Seppänen M
    Neurobiol Aging; 2015 Apr; 36(4):1757-1763. PubMed ID: 25697414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrastriatal
    Nicastro N; Garibotto V; Burkhard PR
    BMC Neurol; 2020 May; 20(1):192. PubMed ID: 32416724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal dopamine transporter binding differs between dementia with Lewy bodies and Parkinson's disease with dementia.
    Ishizawa K; Fujita Y; Nagashima K; Nakamura T; Shibata M; Kasahara H; Makioka K; Taketomi-Takahashi A; Hirasawa H; Higuchi T; Tsushima Y; Ikeda Y
    J Neurol Sci; 2023 Aug; 451():120713. PubMed ID: 37441875
    [No Abstract]   [Full Text] [Related]  

  • 18. [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies.
    van der Zande JJ; Booij J; Scheltens P; Raijmakers PG; Lemstra AW
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1060-6. PubMed ID: 26830298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
    McCleery J; Morgan S; Bradley KM; Noel-Storr AH; Ansorge O; Hyde C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010633. PubMed ID: 25632881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between longitudinal changes in striatal dopamine transporter uptake and clinical features of dementia with Lewy bodies.
    Yamamoto R; Takenoshita N; Inagawa Y; Kato H; Kaneshiro K; Kamiya T; Inagawa S; Saisho A; Tsugawa A; Mastumoto Y; Yoshimura M; Saito K; Shimizu S; Sato T
    Psychogeriatrics; 2023 Nov; 23(6):1036-1042. PubMed ID: 37726104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.